semaglutide shortage end Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list An Ongoing Crisis: Semaglutide Shortage

PlexusDx explains the risks, clinical evidence, and why a single-agent GLP-1 approach may be safer and more effective for your goals

The FDA requires warnings on some drugs due to these interactions, making it essential to check labels and consult healthcare providers.

Here's what the trial data says.

Enteroendocrine L-cell derived peptide hormones, notably glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), have become important targets in the treatment of type 2 diabetes, obesity and intestinal diseases

Plus, the links: anti-inflammatory diets, "nerdy dopamine pathways," surprisingly low levels of weight loss from GLP-1s, and more